Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis

Observational studies have suggested that HER2 inhibition with trastuzumab may be associated with an increased incidence of intracranial metastatic disease (IMD) due to its ability to prolong survival. We hypothesized that prolonged survival associated with dual-agent HER2 inhibition may be associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Anders Wilder, Habbous, Steven, Hoey, Christianne, Jerzak, Katarzyna J., Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892568/
https://www.ncbi.nlm.nih.gov/pubmed/33602948
http://dx.doi.org/10.1038/s41523-021-00220-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892568/
https://www.ncbi.nlm.nih.gov/pubmed/33602948
http://dx.doi.org/10.1038/s41523-021-00220-0

Ejemplares similares